Stay updated on BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL
Sign up to get notified when there's something new on the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page.

Latest updates to the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page
- Check2 days agoChange DetectedUpdated the study locations: Booker Dynamic Brand Solutions was added as a site in Atlanta, GA 30329. The Emory University School of Medicine Winship Cancer Institute site in Atlanta, GA 30322 was removed.SummaryDifference0.2%

- Check9 days agoChange DetectedNo significant changes detected on the BELINDA study page (NCT03570892); core study details appear unchanged and updates are likely minor UI adjustments.SummaryDifference0.3%

- Check30 days agoChange DetectedUpgrade to v3.2.0 with new topic term and a government-status notice; previous v3.1.0 removed. This reflects a core content update and new informational item.SummaryDifference2%

- Check37 days agoChange DetectedCore content updated: replaces 'Diffuse large B-cell lymphoma' with the broader 'B-cell lymphoma' term and updates the revision/version to v3.1.0.SummaryDifference0.2%

- Check51 days agoChange DetectedVersion bump from v3.0.1 to v3.0.2 with removal of the 'Back to Top' link; no substantive changes to core content, pricing, or scheduling.SummaryDifference0.1%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

Stay in the know with updates to BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL
Enter your email address, and we'll notify you when there's something new on the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page.